Outcomes of highly active antiretroviral therapy and its predictors: a cohort study focusing on tuberculosis co-infection in South West Ethiopia

Table 2 Outcomes of ART compared based on TB status, South West Ethiopia, 2012

ART outcomes	Months	TB status		p value
ART outcomes	Months	No (N = 520)	Yes (N = 130)	p value
Clinical failure, N (%)	6	95 (18.3)	46 (35.4)	<0.001**
Clinical failure, N (%)	12	62 (11.9)	38 (29.2)	<0.001**
Immunologic failure, N (%)	6	141 (27.1)	29 (22.3)	<0.001**
Immunologic failure, N (%)	12	102 (19.6)	18 (13.8)	0.043
AIDS defining illness, N (%)	6	27 (5.2)	14 (10.8)	0.005**
AIDS defining illness, N (%)	12	20 (3.8)	11 (8.5)	<0.001
CD4 cells increase, mean ± std. error of mean	6	146.7 ± 7.2	150.5 ± 14.1	0.827*
CD4 cells increase, mean ± std. error of mean	12	180.7 ± 8.1	186.1 ± 17.6	0.780
Hemoglobin increase, mean ± std. error of mean	6	1.0 ± 0.1	1.8 ± 0.4	0.028*
Hemoglobin increase, mean ± std. error of mean	12	1.3 ± 0.1	2.0 ± 0.3	0.046
Weight gain in kg, mean ± std. error of mean	6	2.8 ± 0.2	4.4 ± 0.6	0.008*
Weight gain in kg, mean ± std. error of mean	12	3.9 ± 0.3	5.9 ± 0.8	0.023

** Compared using Chi square test, * compared using independent sample student t test

ISSN: 1756-0500